2025-04-25 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**0) Overview & Key Figures:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company providing health insurance and related services.

* **Cumulative Return (UNH):** 42.19%
* **Cumulative Return (VOO/S&P 500):** 82.57%
* **Return Difference (UNH vs VOO):** -40.4%
* **Relative Divergence Rank:** 3.0% (Indicates UNH's underperformance relative to the S&P 500 is near the lower end of its historical range)

**1) Alpha & Beta Analysis:**

The provided data shows a mixed performance for UNH relative to the S&P 500 over several years.  While CAGR (Compound Annual Growth Rate) is positive in most periods, it fluctuates significantly, and in some periods (2018-2020, 2022-2024, 2023-2025) it experiences substantial negative returns. The Alpha values indicate periods of outperformance (positive Alpha) and underperformance (negative Alpha) relative to the market, highlighting its fluctuating relationship with market risk. The Beta consistently hovers around 0.1 to 0.7, indicating moderate market sensitivity. Market capitalization (Cap(B)) shows continuous growth.  The high Maximum Drawdown (MDD) values highlight the significant risk associated with UNH investments.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 67.0% | 55.4% | 35.0% | 0.1 | 180.1 |
| 2016-2018  | 59.0% | 63.7% | 38.0% | 0.2 | 206.3 |
| 2017-2019  | 45.0% | 63.7% | 11.0% | 0.4 | 247.6 |
| 2018-2020  | -17.0% | 63.7% | -47.0% | 0.6 | 300.2 |
| 2019-2021  | 39.0% | 61.0% | -22.0% | 0.7 | 435.9 |
| 2020-2022  | 32.0% | 66.9% | 24.0% | 0.7 | 466.1 |
| 2021-2023  | 39.0% | 67.8% | 18.0% | 0.4 | 469.8 |
| 2022-2024  | -27.0% | 69.0% | -47.0% | 0.3 | 458.5 |
| 2023-2025  | -44.0% | 75.2% | -65.0% | 0.2 | 386.2 |


**2) Recent Price Movement:**

* **Closing Price:** $424.25
* **5-Day Moving Average:** $431.77
* **20-Day Moving Average:** $521.60
* **60-Day Moving Average:** $509.30

The stock price is currently trading below all three moving averages, suggesting a bearish short-term trend.  The recent price change (-$0.87) indicates a slight downward movement.

**3) Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.4053 (Medium Risk)
* **RSI:** 28.79 (Oversold territory, suggesting potential bounce)
* **PPO:** -3.57 (Negative value indicates bearish momentum)
* **Recent Relative Strength Change (20-day):** -53.5% (Significant short-term underperformance)
* **Expected Return (2+ years):** 410.0% (This represents a significant outperformance of the S&P 500 over the long term but should be treated with caution given inherent uncertainty).

The combination of oversold RSI, negative PPO, and significant recent underperformance suggests a potentially bearish short-term outlook, but the high long-term expected return might be enticing to long-term investors with appropriate risk tolerance.


**4) Recent Earnings Analysis:**

The earnings data shows inconsistent performance. While there are periods of high EPS and revenue growth, there are also periods of significant decline (note the negative EPS in 2024-05-09).  Further investigation into the reasons for these fluctuations is warranted.  Note that there's a duplicate entry for 2024-11-04.

| Date       | EPS  | Revenue       |
|------------|------|----------------|
| 2024-11-04 | 6.56 | $100.82B      |
| 2024-08-09 | 4.58 | $98.86B      |
| 2024-05-09 | -1.53 | $99.80B       |
| 2023-11-06 | 6.31 | $92.36B       |
| 2024-11-04 | 6.31 | $92.36B       |


**5) Financial Information:**

The financial data shows relatively stable revenue, but profit margins have shown some fluctuation. ROE (Return on Equity) also exhibits volatility, with a negative value in Q1 2024, suggesting potential concerns about profitability and efficiency.  Further investigation into the factors driving these changes is needed.

**Revenue and Profitability:**

| Quarter     | Revenue     | Profit Margin |
|-------------|-------------|---------------|
| 2024-12-31  | $100.81B    | 21.14%        |
| 2024-09-30  | $100.82B    | 22.84%        |
| 2024-06-30  | $98.86B     | 22.31%        |
| 2024-03-31  | $99.80B     | 23.05%        |
| 2023-12-31  | $94.43B     | 23.30%        |

**Capital and Profitability:**

| Quarter     | Equity      | ROE           |
|-------------|-------------|---------------|
| 2024-12-31  | $92.66B     | 5.98%         |
| 2024-09-30  | $94.53B     | 6.41%         |
| 2024-06-30  | $89.36B     | 4.72%         |
| 2024-03-31  | $86.69B     | -1.63%        |
| 2023-12-31  | $88.76B     | 6.15%         |


**6) Summary:**

UNH shows significant long-term growth potential, but also considerable short-term volatility and risk, as evidenced by high MDD values and recent price action.  While the long-term expected return is attractive, the current short-term trend is bearish. Investors should carefully consider the risk-reward profile and their own investment horizon before making any investment decisions.  A deeper dive into the underlying drivers of earnings volatility and ROE fluctuations is crucial for a more comprehensive analysis.  The substantial negative Alpha in some periods also warrants further investigation.  The data suggests a cautious approach, possibly favoring a long-term, value-oriented strategy for investors comfortable with higher risk.
